Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles

Mutations are incorporated into the genomes of RNA viruses at an optimal frequency and altering this precise frequency has been proposed as a strategy to create live-attenuated vaccines. However, determining the effect of specific mutations that alter fidelity has been difficult because of the rapid...

Full description

Bibliographic Details
Main Authors: Edward I. Patterson, Kamil Khanipov, Daniele M. Swetnam, Samantha Walsdorf, Tiffany F. Kautz, Saravanan Thangamani, Yuriy Fofanov, Naomi L. Forrester
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/5/546
_version_ 1827716821920251904
author Edward I. Patterson
Kamil Khanipov
Daniele M. Swetnam
Samantha Walsdorf
Tiffany F. Kautz
Saravanan Thangamani
Yuriy Fofanov
Naomi L. Forrester
author_facet Edward I. Patterson
Kamil Khanipov
Daniele M. Swetnam
Samantha Walsdorf
Tiffany F. Kautz
Saravanan Thangamani
Yuriy Fofanov
Naomi L. Forrester
author_sort Edward I. Patterson
collection DOAJ
description Mutations are incorporated into the genomes of RNA viruses at an optimal frequency and altering this precise frequency has been proposed as a strategy to create live-attenuated vaccines. However, determining the effect of specific mutations that alter fidelity has been difficult because of the rapid selection of the virus population during replication. By deleting residues of the structural polyprotein PE2 cleavage site, E3Δ56-59, in Venezuelan equine encephalitis virus (VEEV) TC-83 vaccine strain, non-infectious virus particles were used to assess the effect of single mutations on mutation frequency without the interference of selection that results from multiple replication cycles. Next-generation sequencing analysis revealed a significantly lower frequency of transversion mutations and overall mutation frequency for the fidelity mutants compared to VEEV TC-83 E3Δ56-59. We demonstrate that deletion of the PE2 cleavage site halts virus infection while making the virus particles available for downstream sequencing. The conservation of the site will allow the evaluation of suspected fidelity mutants across alphaviruses of medical importance.
first_indexed 2024-03-10T19:48:11Z
format Article
id doaj.art-f5ac04f1d4f84622a72bbb68c82c49e5
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T19:48:11Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-f5ac04f1d4f84622a72bbb68c82c49e52023-11-20T00:37:39ZengMDPI AGViruses1999-49152020-05-0112554610.3390/v12050546Measuring Alphavirus Fidelity Using Non-Infectious Virus ParticlesEdward I. Patterson0Kamil Khanipov1Daniele M. Swetnam2Samantha Walsdorf3Tiffany F. Kautz4Saravanan Thangamani5Yuriy Fofanov6Naomi L. Forrester7Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pharmacology and Toxicology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pharmacology and Toxicology, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USADepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USAMutations are incorporated into the genomes of RNA viruses at an optimal frequency and altering this precise frequency has been proposed as a strategy to create live-attenuated vaccines. However, determining the effect of specific mutations that alter fidelity has been difficult because of the rapid selection of the virus population during replication. By deleting residues of the structural polyprotein PE2 cleavage site, E3Δ56-59, in Venezuelan equine encephalitis virus (VEEV) TC-83 vaccine strain, non-infectious virus particles were used to assess the effect of single mutations on mutation frequency without the interference of selection that results from multiple replication cycles. Next-generation sequencing analysis revealed a significantly lower frequency of transversion mutations and overall mutation frequency for the fidelity mutants compared to VEEV TC-83 E3Δ56-59. We demonstrate that deletion of the PE2 cleavage site halts virus infection while making the virus particles available for downstream sequencing. The conservation of the site will allow the evaluation of suspected fidelity mutants across alphaviruses of medical importance.https://www.mdpi.com/1999-4915/12/5/546alphavirusarbovirusfidelity mutantsmutation frequency
spellingShingle Edward I. Patterson
Kamil Khanipov
Daniele M. Swetnam
Samantha Walsdorf
Tiffany F. Kautz
Saravanan Thangamani
Yuriy Fofanov
Naomi L. Forrester
Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
Viruses
alphavirus
arbovirus
fidelity mutants
mutation frequency
title Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
title_full Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
title_fullStr Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
title_full_unstemmed Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
title_short Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles
title_sort measuring alphavirus fidelity using non infectious virus particles
topic alphavirus
arbovirus
fidelity mutants
mutation frequency
url https://www.mdpi.com/1999-4915/12/5/546
work_keys_str_mv AT edwardipatterson measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT kamilkhanipov measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT danielemswetnam measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT samanthawalsdorf measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT tiffanyfkautz measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT saravananthangamani measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT yuriyfofanov measuringalphavirusfidelityusingnoninfectiousvirusparticles
AT naomilforrester measuringalphavirusfidelityusingnoninfectiousvirusparticles